Abbott Laboratories 3Q Sales, Earnings Drop
19 Oktober 2022 - 2:15PM
Dow Jones News
By Dean Seal
Abbott Laboratories' adjusted earnings came in above Wall Street
expectations for the third quarter while its net earnings and sales
dropped from last year.
The Abbott Park, Ill.-based healthcare-products company logged
earnings of $1.44 billion, or 81 cents a share, compared with $2.1
billion, or $1.17 cents a share, in the same period a year ago.
Stripping out one-time items, adjusted earnings were $1.15 a
share. Analysts polled by FactSet had been expecting 94 cents a
share.
Net sales were $10.4 billion, down from $10.93 billion last
year. Analysts surveyed by FactSet had been expecting $9.65
billion.
The company said that without foreign-exchange effects, sales
would have increased 1.3% year-over-year.
Shares edged 1.1% lower, to $103.33, in premarket trading.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
October 19, 2022 08:00 ET (12:00 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024